open access
The course and treatment of COVID-19 in heart transplant recipients: A case series from the late phase of the pandemic
Affiliations- 1st Department of Cardiology, Poznan University of Medical Sciences, Heliodor Swiecicki Clinical Hospital in Poznan, Poznań, Poland
- Department of Cardiac, Vascular and Endovascular Surgery and Transplantology in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland
- Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Heliodor Swiecicki Clinical Hospital in Poznan, Poznań, Poland
open access
Abstract
Abstract
Supp./Additional Files (1)
About this articleTitle
The course and treatment of COVID-19 in heart transplant recipients: A case series from the late phase of the pandemic
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Published online
2023-01-22
Page views
103
Article views/downloads
29
DOI
10.33963/KP.a2023.0024
Pubmed
Authors
Alicja Nowak
Justyna Małyszek-Tumidajewicz
Aleksander Araszkiewicz
Hanna Wachowiak-Baszyńska
Magdalena Janus
Stanisław Jankiewicz
Sylwia Iwańczyk
Anna Smukowska-Gorynia
Tomasz Urbanowicz
Marek Jemielity
Maciej Lesiak
Tatiana Mularek-Kubzdela
References (11)- World Health Organization. WHO coronavirus disease (SARS-COV-2) dashboard 2022. Published 2022. . Available online: https://covid19.who.int/. [Accessed: August 11, 2022].
- Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022; 399(10335): 1618–1624.
- Genuardi MV, Moss N, Najjar SS, et al. Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes. J Heart Lung Transplant. 2021; 40(9): 926–935.
- Bottio T, Bagozzi L, Fiocco A, et al. COVID-19 in heart transplant recipients: A multicenter analysis of the northern italian outbreak. JACC Heart Fail. 2021; 9(1): 52–61.
- Kuczaj A, Zakliczyński M, Przybyłowski P, et al. COVID-19 mortality in patients after orthotopic heart transplantation: A single-center one-year observational study. Kardiol Pol. 2022; 80(2): 215–217.
- World Health Organization. Clinical management of COVID-19: living guideline, 15 September 2022. Geneva: World Health Organization; 2022 (WHO/2019-nCoV/Clinical/2022.2). Published September 15, 2022. Available online: www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-2022.2. [Accessed: September 16, 2022].
- Marcondes-Braga FG, Murad CM, Belfort DSP, et al. Characteristics and Outcomes of Heart Transplant Recipients With Coronavirus-19 Disease in a High-volume Transplant Center. Transplantation. 2022; 106(3): 641–647.
- Heldman MR, Kates OS, Safa K, et al. Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic. Am J Transplant. 2022; 22(1): 279–288.
- Flisiak R, Horban A, Jaroszewicz J, et al. Diagnosis and therapy of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of November 12, 2021. Annex no. 1 to the Recommendations of April 26, 2021. Pol Arch Intern Med. 2021; 131(11).
- Duran JM, Lin AY, Barat M, et al. Use of Remdesivir to Treat COVID-19 after Orthotopic Heart Transplant. J Heart Lung Transplant. 2021; 40(4): S20.
- Shafiekhani M, Shahabinezhad F, Niknam T, et al. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? Virol J. 2021; 18(1): 228.
